Nutri Pharmaceuticals Research, Inc. (NPRI) announced it has formed a strategic alliance with SourceOne Global Partners, Chicago, IL to develop proprietary powder forms of SourceOne’s award-winning proprietary ingredients and formulas that will broaden their applications in the nutritional supplement, food, and beverage markets.
"NPRI is proud to join forces with SourceOne, a company focused on innovation and a proven leader in delivering powerfully branded, science-driven products to market,” said Godfrey Yew, CEO of NPRI. “We look forward to working with SourceOne to expand the potential applications of its patented and proprietary ingredients and formulas. We have watched SourceOne grow its compelling portfolio of products and technologies, and have now identified additional opportunities for strategically aligning our interests.“
Ultimately, added Yew, the two firms “share the same vision for delivering greater value and broader functionality of exceptional health and wellness ingredients and formulas through innovative application technology. We like to say that we transform good ingredients into great ingredients.”
According to Jesse Lopez, CEO and Founder of SourceOne, NPRI’s O2P™ technology will allow SourceOne to offer ingredients like CoQsource® Coenzyme Q10 and OmegaChoice™ Concentrated Omega-3 Essential Fatty Acids (EFAs) in free-flowing powders to broaden their applications. O2P™also allows SourceOne to offer these ingredients (alone or in combination) in the VESIsorb® naturally self-assembling association colloidal delivery system that transforms them to become water soluble with dramatically improved absorption. These applications include two-piece powder-filled hard caps and veggicaps, as well as instant powder applications that include beverage powder sachets, meal replacement shakes, protein shakes, and more.
These ingredients and formulas will be converted to powders using NPRI’s patent-pending O2P™ oil-to-powder technology. O2P™ is a process that converts oils, gels, extracts, pastes and other liquid compounds into free-flowing powders without incurring the oxidative effects of heat and oxygen inherent in typical drying processes. This technology does not alter the base characteristics of odor, taste, color or composition of active ingredients, and offers flexibility in concentration levels and choice of carrier matrixes compatible with a product's formulation versus other powderization technologies.
O2P™ uses a gravity flow process that is conducted in an oxygen-free environment. These powders are capable of holding nearly 70% oil content versus 40% from other technologies. Furthermore, carrying agents have been improved to now offer GMO-free, starch, vegetable-based, and other alternatives.
“NPRI’s intellectual property (IP) portfolio is highly complimentary to the relationships SourceOne has already developed with global partners such as Vesifact AG, Baar Switzerland, and Twin Rivers Technologies (TRT), Quincy, MA,” Lopez said. “The synergies created by these partnerships are directly and immediately applicable to SourceOne ingredients and formulas in various forms and concentrations. The many benefits obtained from these innovations and the IP technology exchange within the SourceOne ‘global partner’ network will resonate with our client partners and ultimately the medical community and consumers focused on health and wellness.”
SourceOne is the exclusive worldwide marketing partner for Vesifact’s patented VESIsorb® naturally self-assembling association colloidal delivery system that improves absorption of nutritional supplements, food, beverage and cosmetic ingredients to enhance product performance. SourceOne recently launched VESIsorb® for Coenzyme Q10 (branded CoQsource®) in both the ubiquinone and ubiquinol (QH) forms.
SourceOne also serves as the exclusive marketing partner for TRT’s U.S.-produced concentrated omega-3 EFAs in the nutritional supplement market. Branded OmegaChoice™, these omega-3 EFAs have GRAS status and contain the highest percent EPA and DHA as a triglyceride that is currently available in the global marketplace.
NPRI has worked with SourceOne for several years providing O2P™ oil-to-powder technology expertise for SourceOne’s proprietary and synergistic ingredients TocoSource® Palm Tocotrienols and PMFsource™ Citrus Flavonoids used in SourceOne’s award-winning Cholesstrinol™ Formulas.
NPRI is one of a select few to be awarded the prestigious Nutrition Business Journal "Product Merit Award" for its patent-pending O2P™ powderization process. At the heart of its oil powders is the O2P™ oil-to-powder technology. This patent-pending process converts most edible oils, gels or pastes into a free-flowing powder without affecting the isomeric structure, fatty acid profile, color, taste or aroma of the base oil. O2P™ does not rely on traditional techniques that utilize extremes in heat or cold, micro-encapsulation or nano technology. This facilitates food marketing and supplement producers' ability to create functional foods and nutraceuticals by adding anti-oxidants, specific EFAs, or other fatty acids such as EPA, GLA, DHA, and CLA to assist in maintaining specific health issues.
Nutri Pharmaceuticals Research Inc. (www.o2pus.com) provides a wide range of powdered oils for functional food, food supplement, pharmaceutical, cosmetic, pet food and animal feed applications. The company currently offers more than 50 shelf-stable powders. The company can also apply O2P™ technology to a third-party's oil, paste or gel through an arrangement called tolling. Based in Las Vegas, the company has representative sales offices near Chicago, Amsterdam, Guatemala City and Bangkok. Nutri Pharmaceuticals Research Inc. shares are currently traded in the United States on the "Pinksheets" under the symbol NRPR.PK. O2P™ is a trademark of Nutri Pharmaceuticals Research, Inc.
About SourceOne Global Partners:
SourceOne™ Global Partners, headquartered in Chicago, IL, represents a new breed of ingredient supplier, partnering with manufacturing clients to introduce powerfully branded, science-driven products to market with unique product positioning and compelling consumer presence. SourceOne was conceived as a company whose core competency would be to integrate legitimate science with strong trade and consumer branding. It partners with leading suppliers worldwide to source and offer patented ingredients supported by proprietary science as part of turnkey marketing programs that dramatically increases the odds for market success. OmegaChoice™, CoQsource®, VESIsorb®, and Cholesstrinol™ are trademarks of SourceOne Global Partners.